California Cancer Associates for Research and Excellence

Escondido, California 92025

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Non-Small Cell Lung Cancer Clinical Trial
M7824 Versus Pembrolizumab as a First-line (1L) Treatment in Participants With Programmed Death-ligand 1 (PD-L1) Expressing Advanced Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling, Phase II
Updated: 12/31/1969
California Cancer Associates for Research and Excellence
mi
from
Escondido, CA
Click here to add this to my saved trials